
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current BOVNF market cap is 309.28M. The company's latest EPS is SEK -5.0195 and P/E is -0.94.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
Total Revenue | 93.74M | 147.37M | 19.38M | 326.13M | 71.46M |
Operating Income | -137M | -74.96M | -278.17M | -50.47M | -370.56M |
Net Income | -138.63M | -76.33M | -278.44M | -42.5M | -330.3M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
Total Assets | 226.11M | 802.64M | 1.45B | 1.71B | 1.4B |
Total Liabilities | 56.68M | 59.14M | 80.32M | 106.09M | 90.45M |
Total Equity | 169.44M | 743.5M | 1.37B | 1.61B | 1.31B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
Operating | -125.43M | -62.62M | -245.84M | -41.23M | -341.69M |
Investing | -3.84M | -6.7M | -467.54M | -628.85M | 59.68M |
Financing | 214.39M | 644.62M | 894.87M | 273.49M | 23.14M |
Market Cap | 309.28M |
Price to Earnings Ratio | -0.94 |
Price to Sales Ratio | 4.33 |
Price to Cash Ratio | 1.19 |
Price to Book Ratio | 0.24 |
Dividend Yield | - |
Shares Outstanding | 65.8M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | 0.00% |
52 Week High | 4.70 |
52 Week Low | 4.70 |
Spread (Intraday) | 0 (0%) |
Company Name | Bioinvent International AB (PK) |
Address |
the gamma building lund SE-223 70 |
Website | https://www.bioinvent.com |
Industry | drugs-health r&d/testing labs (H8) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions